Managing Physical Occupational Speech Therapy and Rehabilitation Care Edition Update

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Oct 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Brinzolamide  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Brinzolamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • October 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Duloxetine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Duloxetine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • October 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States

Sildenafil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Sildenafil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • October 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Sitagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Sitagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • October 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States

Temsirolimus  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Temsirolimus - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • October 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Donepezil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Donepezil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • October 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Irbesartan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Irbesartan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • October 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Rivastigmine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Rivastigmine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • October 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Ropinirole  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Ropinirole - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • October 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.